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Abstract: The purpose of this study was to examine the role of persistent symptoms of depression
and anxiety in a second acute coronary syndrome (ACS) event. Data presented in this study were
from an RCT study. A follow-up for 24 months after baseline to detect a second ACS event among
1162 patients from five hospitals. Hierarchal Cox regression analyses were used. The results showed
that persistent depression only (HR 2.27; 95% CI: 1.35–3.81; p = 0.002), and comorbid persistent
depression and anxiety (HR 2.03; 95% CI: 1.03–3.98; p = 0.040) were the significant predictors of
a second ACS event. Secondary education level compared to primary educational level (HR 0.63;
95% CI: 0.43–0.93; p = 0.020) and college or more education level compared to primary educational
level (HR 0.47; 95% CI: 0.27–0.84; p = 0.011) were the only demographic variables that were significant
predictors of a second event. The study reveals that attention must be paid by healthcare providers to
assess and manage persistent depression; particularly when it is co-morbid with anxiety.
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1. Introduction
Coronary artery disease is the number one killer in the world [1]. Acute coronary
syndrome (ACS) is an umbrella term used to cover any condition that reduces blood flow
to cardiac muscle and leads to signs and symptoms of acute myocardial ischemia [1].
ACS includes unstable angina, non-ST elevation myocardial infarction (NSETMI), and
ST-elevation myocardial infarction (STEMI) and these conditions may progress to serious
complications like heart failure or death [2]. Caring of individuals with ACS requires
understanding of undermining reasons and antecedents that may include psychological
ones. Recent studies also have emphasized the role of gender, physical fitness, obesity, age,
and therapeutic regimens in developing ACS [3,4]. Such factors also vary depending on
other intrinsic and biological factors that are associated with and influenced by medication
and treatment protocol used following acute cardiac injury [5]. Therefore, the connection
between psychological factors such as depression and anxiety might act reciprocally with
ACS either causing or jeopardizing the occurrence and consequences of second ACS [6].
Depression is a serious mental illness that interferes with individual’s ability to function normally, socially and occupationally. Studies showed that depression is becoming
prevalent among patients with coronary artery diseases. It has been reported that 20% of
patients admitted to hospital with ACS meet the criteria of major depression symptoms
reported by DSM-5 [7]. Such percentage might be increased in patients with ACS [7].
Although studies linked depressive symptoms to ACS morbidity and mortality rates [7–9],
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the co-occurrence of depression and anxiety is not well addressed [1]. Connecting the cooccurrence of depression and anxiety among patients with ACS is assumed to compromise
patients’ wellbeing and recovery due to assumed social and occupational dysfunctions
that might also occur due to anxiety [10–12]. However, addressing the persistent state of
depression and anxiety among patients with ACS is rarely discussed, as well [10–12]. In
such situations, the co-occurrence of depression and anxiety in patients with ACS provides
more complex understanding for a second ACS. The notion that physical symptoms create
psychological response, and that psychological responses would exacerbate the physical
symptoms might be applicable in such situations [13,14]. Readmission and depression have
been reported for those with ACS in the ensuing two years [13]. Such connection has been
also reported with number of limitations including adherence, dieting, and psychological
counseling [13]. On the other hand, other studies have indicated that anxiety and depression have been reported prior the first ACS [15]. The question remains whether anxiety
and depression did contribute to first and second ACS or the consequences of physical
symptoms of the first ACS did cause the occurrence of a second ACS [16]. However, there is
limited information in the literature regarding the association of persistent depression and
anxiety with recurrent ACS. This study provides an understanding for such an issue. Thus,
the purpose of this study was to investigate the role of persistent symptoms of depression
and anxiety in second ACS event. The specific aims were:
-

To assess the persistent anxiety and depression among patients with second ACS event.
To identify the relationship between persistent anxiety and depression and second
ACS event.

2. Materials and Methods
Data presented in this study were from a randomized controlled trial called ACS Delay
Time Intervention Trial [17]. The trial examined the effect of an educational intervention
on knowledge attitudes, beliefs, and the pre-hospital delay time in patients diagnosed
with ACS [12,17]. Patients’ enrollments took place in five hospitals (N = 1162). Patients
were recruited from coronary care units, and cardiology floors after eligibility screening
had been done by nurses who worked in these hospitals. Patients have been clustered
to describe the presence of symptoms of depression and anxiety at baseline. A cut-off
point has also been created at 75th percentile. This process was repeated at three months
follow-up period. Patients were clustered, then, into four groups according to existence
of persistent depression and anxiety as follows: (1) none, (2), had persistent depression
only; (3) had persistent anxiety only, and (4) has both persistent depression and persistent
anxiety. Those who have been diagnosed with ACS, undergoing discharge were considered
eligible for participation (See flow diagram 1). While those institutionalized, diagnosed
with serious cognitive or physical disability that interferes with their ability to comprehend,
understand, and answer the question, and those with serious medical complications were
excluded from the study. Prior to being included in the study, information about the study
and its significance were discussed with those who expressed interest in participation.
The information was introduced in verbal and written format. Eligible and interested
candidates were recruited by a research nurse who obtained signed consent and collected
data through interviews and medical record review. Once informed consent signed and the
patients are clinically stabilized according to primary caregivers, data were collected prior
discharge and then follow-up over the phone. Those who have been readmitted to the unit
were followed up and checked to confirm the second ACS.
Symptoms of depression and anxiety were measured using The Multiple Adjective
Affect Checklist (MAACL) 15. The MAACL contains 132 alphabetically organized adjectives. Patients were asked to select those adjectives that described how they felt. Those
with higher scores are more likely to suffer anxiety and depression. The 75th percentile has
been created as a cutoff point for those classified with anxiety or depression. The scale has
good internal consistency, stability, construct, and concurrent validity. Cronbach’s alpha
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for the MAACL was reported to be 0.82 for the Anxiety Scale and 0.81 for the Depression
Scale [18,19].
To measure for the second ACS, a month-based follow-up phone call and electronic
and non-electronic chart reviews were used to determine dates for hospitalizations. Patients were followed for at least 24 months after baseline to detect second ACS events.
Demographic and clinical information were also collected at baseline from patients along
with their medical records by interviewing patients and by reviewing their electronic
and non-electronic charts. These variables include age, gender, marital status, education
level, smoking history, body mass index (BMI), hypertension history (HTN), and diabetes
history (DM).
The patients were informed that participation is strictly voluntary and deciding not to
take part in the study would not pose any disadvantage to them. The participants were
informed that the information they share in the survey are confidential and the data would
be locked in a password protected folder in a PC of the investigators. The work described
was carried out in accordance with The Code of Ethics of the World Medical Association
(Declaration of Helsinki) for experiments involving humans; Uniform Requirements for
manuscripts submitted to biomedical journals.
Data were analyzed using the IBM-SPSS 25. Descriptive statistics (Mean, median,
model), dispersion measures (SD, variance), and interpercentile measures were used to
describe the variables of the study. t-test, ANOVA, and chi-square were used to compare
the group differences.
Hierarchal Cox proportional regression analyses were used to determine whether
co-morbid persistent symptoms of depression and anxiety, independently, predicted the
second ACS event. Data were entered into the regression in three blocks. The following
covariates were considered: age, gender, marital status, education level, smoking history,
BMI, HTN, and DM. In the first block, demographic variables (i.e., age, gender, marital
status and education level) were entered. In the second block, clinical variables (i.e.,
smoking history, BMI, HTN, and DM)) were entered. In the final block, depression and
anxiety group was entered into the model. The assumptions of hierarchal Cox proportional
hazards modeling were tested, and no violations occurred. p-value was set at 0.05.
3. Results
3.1. Demographic Characteristics
Demographic and clinical characteristics of patients (N = 1162) are summarized
in Table 1. The mean level of depression and anxiety at baseline were 10.29 ± 3.69,
18.70 ± 4.46, respectively. The mean level of depression and anxiety decreased at three
months follow-up period to 7.97 ± 4.40 and 16.13 ± 6.29, respectively. A total of 74 (7.0%)
patients had persistent depressive symptoms only, 47 (4.4%) had persistent anxiety symptoms
only, 56 (5.3%) had co-morbid persistent symptoms of depression and anxiety, and the remaining 880 (83.3%) had no present anxiety or depression. A total of 136 (11.3 %) participants
had a second ACS event described as the following: 6 participants (0.5%) had STEMI,
14 participants (1.2%) had NSTEMI, and 116 participants (9.7%) had unstable angina.
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Table 1. Sample baseline characteristics (N = 1162).
Characteristic

N (%) or MEAN ± SD

Age
Anxiety score (baseline)
Anxiety score (3 months)
Depressive symptoms score (baseline)
Depressive symptoms score (3 months)
Anxiety and depression categories
No persistent Anxiety or Depression
Persistent depression Only
Persistent anxiety Only
Co-morbid persistent anxiety and depression

63.45 ± 11.90
10.29 ± 3.69
7.97 ± 4.40
18.70 ± 4.46
16.13 ± 6.29

BMI

846 (72.8)
316 (27.2)

Marital status
Single/separated/widowed/divorced
Married/ living with someone
Education Level
Little or primary level completed
Secondary level completed
College or higher
Current smoker
HTN
Diabetes mellitus

880 (83.3)
74 (7.0)
47 (4.4)
56 (5.3)

396 (34.1)
766 (65.9)
417 (35.9)
523 (45.0)
222 (19.1)
575 (49.5)
682 (58.7)
190 (16.3)

3.2. Regression Analysis
Hierarchal Cox regression was run for the depression and anxiety group treated as a
categorical variable and second ACS event as the outcome. In the first block, demographic
variables (i.e., age, gender, marital status, and education level) were entered. In this block,
only secondary education level compared to primary educational level (HR 0.60; 95% CI:
0.40–0.88; p = 0.009) and college or higher compared to primary educational level (HR 0.44;
95% CI: 0.25–0.78; p = 0.005) were significant predictors of second ACS event.
In the second block, clinical variables (i.e., smoking history, BMI, HTN, and DM)
were entered. Secondary education level compared to primary educational level (HR 0.60;
95% CI: 0.41–0.89; p = 0.011) and college or more education level compared to primary
educational level (HR 0.45; 95% CI: 0.26–0.81; p = 0.007) remained the only significant
predictors of second ACS event. In the final block, depression and anxiety group was
entered into the model. The final model demonstrated that secondary education level
compared to primary educational level (HR 0.63; 95% CI: 0.43–0.93; p = 0.020), college or
more education level compared to primary educational level (HR 0.47; 95% CI: 0.27–0.84;
p = 0.011), persistent depression only (HR 2.27; 95% CI: 1.35–3.81; p = 0.002), and comorbid
persistent depression and anxiety (HR 2.03; 95% CI: 1.03–3.98; p = 0.040) were the significant
predictors of second ACS event. Patients with persistent depression are 2.27 times more
likely to have a second ACS event compared to those who do not have persistent depression
or anxiety. In addition, patients with comorbid persistent depression and anxiety are
2.03 times more times more likely to have a second ACS event compared to those who do
not have persistent depression or anxiety (Table 2, Figure 1).
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Table 2. Cox proportional hazard regression of variables associated with ACS second event, and
anxiety and depression treated as categorical variables.
Predictor Variables

Odds Ratio

95% CI

P

1.00
1.41
0.60
0.44

0.98–1.01
0.97–2.06
0.40–0.88
0.25–0.78

0.617
0.075
0.009
0.005

0.79

0.55–1.15

0.220

1.00
0.92
0.60
0.45

0.98–1.01
0.95–2.03
0.41–0.89
0.26–0.81

0.725
0.092
0.011
0.007

0.79

0.54–1.15

0.220

1.00
1.20
0.92
1.02

0.69–1.44
0.81–1.75
0.57–1.50
0.98–1.05

0.977
0.362
0.743
0.438

Age
1.00
0.98–1.02
Female Gender
0.31
0.83–1.81
Secondary education compared to primary
0.63
0.43–0.93
College or more education compared to primary
0.47
0.27–0.84
Married/living with someone compared to
0.81
0.56–1.18
Healthcare single/separated/widowed/divorced
2022, 10, x FOR PEER REVIEW
Smoker compared to non-smoker
0.96
0.66–1.39
Hypertensive compared to not hypertensive
1.19
0.81–1.75
Diabetic compared to not diabetic
0.87
0.53–1.41
Comorbid Persistent
BMI
0.47
0.98–1.05
anxiety and
2.03 2.27
1.03–3.98
Persistent depression Only
1.35–3.81
depression
Persistent anxiety Only
1.81
0.89–3.66
(χ2 = 37.14, df. = 12; p < 0.001)
Comorbid Persistent anxiety and depression Overall Model 2.03
1.03–3.98

0.944
0.311
0.020
0.011

Block I
Age
Female Gender
Secondary education compared to primary
College or more education compared to primary
Married/living with someone compared to
single/separated/widowed/divorced
Block II
Age
Female Gender
Secondary education compared to primary
College or more education compared to primary
Married/living with someone compared to
single/separated/widowed/divorced
Smoker compared to non-smoker
Hypertensive compared to not hypertensive
Diabetic compared to not diabetic
BMI
Block III (Final Model)

0.278

6 of 9

0.821
0.388
0.560
0.470
0.040
0.002
0.100
0.040

Overall Model (χ2 = 37.14, df. = 12; p < 0.001)
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4. Discussion

4. Discussion
The comorbidity of psychological and medical problems is no more a discussion point,
and rather, a point of agreement. Researchers are almost in agreement with that a reciprocal
relationship exists between medical and psychological problems [20,21]. We found in this
study that persistent depression and comorbid persistent depression and anxiety were
statistically significant predictors of a second ACS event; persistent depression was the
strongest predictor. Theoretically, it would appear that comorbid persistent depression
and anxiety would have a stronger effect than persistent depression only. However, the
combination of comorbid persistent depression and anxiety was the second strongest
predictor for the second ACS. Anxiety alone was not a significant predictor, which could
explain that anxiety did not add power to the prediction of second ACS; on the contrary,
it has attenuated the effect of depression. The results do support previous reports that
persistent symptoms depression and anxiety has increased the risk of mortality in patients
with cardiac problems [15,22]. One explanation is that depression and anxiety symptoms
such as insomnia, loss of energy, weight issues, decreased pain tolerance, headache, and
gastrointestinal problems might have added to cardiogenic factors related to ACS. The
significant role of depression in second ACS, however, indicates the overlap and exacerbates
the effect of psychosomatic problems on the patients’ wellbeing. In other words, the origin
of symptoms whether due to depression or to cardiac effect might add to patients’ burden
of disease causing further psychosomatic effect that contributed to second ACS. Such an
explanation supports the notion that a second ACS event is likely a physiological sequels of
the maladaptive behaviors associated with depression [23]. Worth to add here that factors
that might also contribute to second ACS might be patient-related. For example, depressed
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patients are more reluctant to comply with suggested care protocols, attend follow-up
visits, or make behavioral changes that could insulate them from second ACS events [7]. In
addition, those patients are more likely to withdraw prescribed medications that affects
efficacy of drugs and the intended outcomes of treatment protocol. It has been found
that young and old people and being female are associated with lack of adherence among
patients post cardiac infarction [24]. This might also confirm the significant contribution of
depression while anxiety was not an influencing factor.
The literature emphasized the role of depression in developing serious complications
and mortality in patients with ACS [7]. The risk of ACS recurrence or even mortality is high
among patients whose depressive symptoms are persist or resistant to treatment [7,14,15].
Therefore, management of cardiac problems requires that healthcare professionals work
collaboratively to address psychological and physiological underlying reasons related to
ACS upon the first admission and making a critical follow-up to address the influence of
depressive symptom on receiving appropriate care to prevent second ACS. Furthermore,
with regard to the high risk of second ACS reported in this study, patients with persistent depression are about 2.3 times more likely to have a second ACS attack compared
to those who do not have, do add to the body of knowledge counteracting the treatment
guideline proposed by the American Heart Association which does not include depression
as risk factor for poor prognosis among patients with cardiogenic problem [7,14]. Our
results do support the very recent study that risk of heart disease are much higher (up to
2.5 fold) among patients with psychiatric disorders compared to those who are not. Although persistent depression and anxiety does not count as psychiatric disorders, the severe
forms might increase the vulnerability to psychiatric illness and further psychosomatic
problems [25]. One significant issue to raise here related to variation in report that connects
psychological problems and cardiac disease is related to approaches used to identify psychological and psychiatric disorders. Psychiatric disorders need to be confirmed through
clinical observation of criteria advised by DSM-5 for example. However, patients may
have some of these criteria and still not diagnosed which might be described as depressive
symptomatology. Such an issue is ignored in the literature where depression has been
identified as a disorder or just a group of depressive symptoms. Nevertheless, untreated
depressive symptoms might progress to disorders causing more harm to patient. This
indicates that health care professionals including nurses need to be aware of the negative
effect of depressive symptoms and its severity which might be non-diagnosable but might
exacerbate to influence the patient’s wellbeing causing second ACS.
Regarding the sociodemographic factors, we found that education was a significant
predictor, while gender and age were not. This indicates that the role of sociodemographic
factors in second CS is minimal compared to psychological factors. Although age and
gender play a significant role in defining severity of chest pain, their role as predictors of
second ACS is not significant supporting previous findings in this field [7,23,26].
One limitation of this study is related to data collection process in which more unstructured format of data collection regarding depression and its role in adherence to medical
regimen among patient with cardiac problems might reveal more information and better
understanding. Another limitation is related to the lack of comparative data with patients
without ACS that might reveal more informative results.
5. Conclusions
This study attempted to investigate the role of persistent depression and anxiety
in second ACS. We found that second ACS is common and prevalent among those with
depression and less with those of anxiety. Moreover, educated people showed more positive
outcomes, and age and gender are not associated with second ACS. The study infers a
need to manage depression among patients with ACS to prevent second ACS due to the
significant role of depression in lack of adherence to medical regiment after discharge.
The study has implications to nurses in cardiology units and to all other psychology and
healthcare professionals. Cardiology nurses need to connect psychological antecedents of
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cardiac problems and the higher risk for second ACS among those with depression and
anxiety. Thus, assessment of psychosomatic signs and symptoms has to be a priority and
should be integrated in the routine nursing care plans for patients admitted with ACS.
Follow-up care also has to emphasize the signs and symptoms of depression and anxiety as
one proposed measure to prevent second ACS and due to the significant role of depression
in lack of adherences and second ASC. Managing psychological problems related to cardiac
problems is also a priority. Future investigators should attempt to determine why persistent
depression alone is a stronger predictor of a second ACS event.
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